<?xml version="1.0" encoding="UTF-8"?>
<p>Zika virus (ZIKV) is a historically neglected mosquito-borne flavivirus first isolated in 1947 that, until recently, typically resulted in a handful of documented cases with mild clinical phenotypes. Beginning in 2007, larger outbreaks of the virus were first recorded, culminating in a large epidemic in the western hemisphere in 2015–2016 [
 <xref rid="CIT0001" ref-type="bibr">1–4</xref>]. For the first time, ZIKV infection has been associated with severe symptoms including microcephaly in infants infected as fetuses, and Guillain-Barré syndrome in adults [
 <xref rid="CIT0005" ref-type="bibr">5</xref>,
 <xref rid="CIT0006" ref-type="bibr">6</xref>]. Considering the impacts of ZIKV on infants exposed 
 <italic>in utero</italic> and its rapid spread, the World Health Organization (WHO) declared ZIKV a public health emergency of international concern [
 <xref rid="CIT0007" ref-type="bibr">7</xref>]. The occurrence of severe clinical outcomes for fetuses and pregnant women in this outbreak has stimulated interest in determining the factors governing ZIKV infection [
 <xref rid="CIT0008" ref-type="bibr">8</xref>,
 <xref rid="CIT0009" ref-type="bibr">9</xref>].
</p>
